1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, and Trends
4. Voice
of Customer
5. Clinical
Trial Analysis
6. Patent
Analysis
7. Global
Liquid Biopsy Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1. By
Offering (Testing Service, Kits, Platform, Other Consumables)
7.2.2. By
Technology (Polymerase Chain Reactions, Next Generation Sequencing, Others)
7.2.3. By Workflow
(Sample Preparation, Library Preparation, Sequencing, Data Analysis &
Management)
7.2.4. By Sample
(Blood, Urine, Saliva, Others)
7.2.5. By Circulating
Biomarker (Circulating Tumor Cells (CTCs), Cell Free Nucleic Acids, Exosomes
& Extracellular Vesicles, Others)
7.2.6. By Application
(Oncological and non-Oncological)
7.2.6.1.
By Oncological (Breast Cancer, Lung Cancer, Prostate
Cancer, Colorectal Cancer, Others)
7.2.6.2.
By Non-Oncological (Treatment Monitoring, Prognosis
& Recurrence Monitoring, Treatment Selection, Others)
7.2.7. By End
User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical
& Biotechnology Companies)
7.2.8. By
Company (2023)
7.2.9. By
Region
7.3. Market
Map
8. North
America Liquid Biopsy Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Offering
8.2.2. By
Technology
8.2.3. By
Workflow
8.2.4. By
Sample
8.2.5. By
Circulating Biomarker
8.2.6. By
Application
8.2.7. By
End User
8.2.8. By
Country
8.3. North
America: Country Analysis
8.3.1. United
States Liquid Biopsy Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Offering
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Workflow
8.3.1.2.4.
By Sample
8.3.1.2.5.
By Circulating Biomarker
8.3.1.2.6.
By Application
8.3.1.2.7.
By End User
8.3.2. Mexico
Liquid Biopsy Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Offering
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Workflow
8.3.2.2.4.
By Sample
8.3.2.2.5.
By Circulating Biomarker
8.3.2.2.6.
By Application
8.3.2.2.7.
By End User
8.3.3. Canada
Liquid Biopsy Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Offering
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Workflow
8.3.3.2.4.
By Sample
8.3.3.2.5.
By Circulating Biomarker
8.3.3.2.6.
By Application
8.3.3.2.7.
By End User
9. Europe
Liquid Biopsy Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1. By
Offering
9.2.2. By
Technology
9.2.3. By
Workflow
9.2.4. By
Sample
9.2.5. By
Circulating Biomarker
9.2.6. By
Application
9.2.7. By
End User
9.2.8. By
Country
9.3. Europe:
Country Analysis
9.3.1. France
Liquid Biopsy Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Offering
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Workflow
9.3.1.2.4.
By Sample
9.3.1.2.5.
By Circulating Biomarker
9.3.1.2.6.
By Application
9.3.1.2.7.
By End User
9.3.2. Germany
Liquid Biopsy Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Offering
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Workflow
9.3.2.2.4.
By Sample
9.3.2.2.5.
By Circulating Biomarker
9.3.2.2.6.
By Application
9.3.2.2.7.
By End User
9.3.3. United
Kingdom Liquid Biopsy Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Offering
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Workflow
9.3.3.2.4.
By Sample
9.3.3.2.5.
By Circulating Biomarker
9.3.3.2.6.
By Application
9.3.3.2.7.
By End User
9.3.4. Italy
Liquid Biopsy Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Offering
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Workflow
9.3.4.2.4.
By Sample
9.3.4.2.5.
By Circulating Biomarker
9.3.4.2.6.
By Application
9.3.4.2.7.
By End User
9.3.5. Spain
Liquid Biopsy Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Offering
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Workflow
9.3.5.2.4.
By Sample
9.3.5.2.5.
By Circulating Biomarker
9.3.5.2.6.
By Application
9.3.5.2.7.
By End User
10. Asia-Pacific
Liquid Biopsy Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1. By
Offering
10.2.2. By Technology
10.2.3. By
Workflow
10.2.4. By
Sample
10.2.5. By
Circulating Biomarker
10.2.6. By
Application
10.2.7. By
End User
10.2.8. By
Country
10.3.
Asia-Pacific: Country Analysis
10.3.1. China
Liquid Biopsy Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Offering
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Workflow
10.3.1.2.4.
By Sample
10.3.1.2.5.
By Circulating Biomarker
10.3.1.2.6.
By Application
10.3.1.2.7.
By End User
10.3.2. India
Liquid Biopsy Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Offering
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Workflow
10.3.2.2.4.
By Sample
10.3.2.2.5.
By Circulating Biomarker
10.3.2.2.6.
By Application
10.3.2.2.7.
By End User
10.3.3. South
Korea Liquid Biopsy Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Offering
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Workflow
10.3.3.2.4.
By Sample
10.3.3.2.5.
By Circulating Biomarker
10.3.3.2.6.
By Application
10.3.3.2.7.
By End User
10.3.4. Japan
Liquid Biopsy Market Outlook
10.3.4.1. Market
Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market
Share & Forecast
10.3.4.2.1.
By Offering
10.3.4.2.2.
By Technology
10.3.4.2.3.
By Workflow
10.3.4.2.4.
By Sample
10.3.4.2.5.
By Circulating Biomarker
10.3.4.2.6.
By Application
10.3.4.2.7.
By End User
10.3.5. Australia
Liquid Biopsy Market Outlook
10.3.5.1. Market
Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market
Share & Forecast
10.3.5.2.1.
By Offering
10.3.5.2.2.
By Technology
10.3.5.2.3.
By Workflow
10.3.5.2.4.
By Sample
10.3.5.2.5.
By Circulating Biomarker
10.3.5.2.6.
By Application
10.3.5.2.7.
By End User
11. South
America Liquid Biopsy Market Outlook
11.1.
Market Size & Forecast
11.1.1. By
Value
11.2.
Market Share & Forecast
11.2.1. By
Offering
11.2.2. By
Technology
11.2.3. By
Workflow
11.2.4. By
Sample
11.2.5. By
Circulating Biomarker
11.2.6. By
Application
11.2.7. By
End User
11.2.8. By
Country
11.3.
South America: Country Analysis
11.3.1. Brazil
Liquid Biopsy Market Outlook
11.3.1.1. Market
Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market
Share & Forecast
11.3.1.2.1.
By Offering
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Workflow
11.3.1.2.4.
By Sample
11.3.1.2.5.
By Circulating Biomarker
11.3.1.2.6.
By Application
11.3.1.2.7.
By End User
11.3.2. Argentina
Liquid Biopsy Market Outlook
11.3.2.1. Market
Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market
Share & Forecast
11.3.2.2.1.
By Offering
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Workflow
11.3.2.2.4.
By Sample
11.3.2.2.5.
By Circulating Biomarker
11.3.2.2.6.
By Application
11.3.2.2.7.
By End User
11.3.3. Colombia
Liquid Biopsy Market Outlook
11.3.3.1. Market
Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market
Share & Forecast
11.3.3.2.1.
By Offering
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Workflow
11.3.3.2.4.
By Sample
11.3.3.2.5.
By Circulating Biomarker
11.3.3.2.6.
By Application
11.3.3.2.7.
By End User
12. Middle
East and Africa Liquid Biopsy Market Outlook
12.1.
Market Size & Forecast
12.1.1. By
Value
12.2.
Market Share & Forecast
12.2.1. By
Offering
12.2.2. By
Technology
12.2.3. By
Workflow
12.2.4. By
Sample
12.2.5. By
Circulating Biomarker
12.2.6. By
Application
12.2.7. By
End User
12.2.8. By
Country
12.3.
MEA: Country Analysis
12.3.1. South
Africa Liquid Biopsy Market Outlook
12.3.1.1. Market
Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2. Market
Share & Forecast
12.3.1.2.1.
By Offering
12.3.1.2.2.
By Technology
12.3.1.2.3.
By Workflow
12.3.1.2.4.
By Sample
12.3.1.2.5.
By Circulating Biomarker
12.3.1.2.6.
By Application
12.3.1.2.7.
By End User
12.3.2. Saudi
Arabia Liquid Biopsy Market Outlook
12.3.2.1. Market
Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2. Market
Share & Forecast
12.3.2.2.1.
By Offering
12.3.2.2.2.
By Technology
12.3.2.2.3.
By Workflow
12.3.2.2.4.
By Sample
12.3.2.2.5.
By Circulating Biomarker
12.3.2.2.6.
By Application
12.3.2.2.7.
By End User
12.3.3. UAE Liquid
Biopsy Market Outlook
12.3.3.1. Market
Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2. Market
Share & Forecast
12.3.3.2.1.
By Offering
12.3.3.2.2.
By Technology
12.3.3.2.3.
By Workflow
12.3.3.2.4.
By Sample
12.3.3.2.5.
By Circulating Biomarker
12.3.3.2.6.
By Application
12.3.3.2.7.
By End User
13. Market
Dynamics
13.1.
Drivers
13.2.
Challenges
14. Market
Trends & Developments
14.1.
Merger & Acquisition (If Any)
14.2.
Product Launches (If Any)
14.3.
Recent Developments
15. Porters
Five Forces Analysis
15.1.
Competition in the Industry
15.2.
Potential of New Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute Products
16. Competitive
Landscape
16.1.
F. Hoffmann-La Roche Ltd
16.1.1.
Business Overview
16.1.2.
Company Snapshot
16.1.3.
Products & Services
16.1.4.
Financials (As Reported)
16.1.5.
Recent Developments
16.1.6.
Key Personnel Details
16.1.7.
SWOT Analysis
16.2.
Thermo Fisher Scientific, Inc.
16.3.
PerkinElmer Inc.
16.4.
LungLife AI, Inc.
16.5.
Illumina, Inc.
16.6.
QIAGEN NV
16.7.
NeoGenomics Laboratories, Inc.
16.8.
Myriad Genetics, Inc.
16.9. Bio-Rad Laboratories, Inc.
16.10. Guardent Health Inc.
16.11. Natera, Inc.
16.12. Sysmex Corporation
16.13. Abcodia Ltd.
16.14. Dxcover Limited
17. Strategic
Recommendations
18. About
Us & Disclaimer